Insider Transactions in Q2 2021 at Paratek Pharmaceuticals, Inc. (PRTK)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Minnie Baylor Henry Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,200
+50.0%
|
-
|
|
Jun 04
2021
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
36,654
-3.68%
|
$329,886
$9.7 P/Share
|
|
Jun 04
2021
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
34,364
-3.76%
|
$309,276
$9.7 P/Share
|
|
Jun 04
2021
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
9,978
-3.58%
|
$89,802
$9.7 P/Share
|
|
Jun 04
2021
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
7,561
-2.07%
|
$68,049
$9.7 P/Share
|
|
Jun 04
2021
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
17,182
-3.49%
|
$154,638
$9.7 P/Share
|
|
May 27
2021
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
91,636
+8.43%
|
-
|
|
May 27
2021
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
85,909
+8.59%
|
-
|
|
May 27
2021
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
28,636
+9.31%
|
-
|
|
May 27
2021
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
28,636
+7.28%
|
-
|
|
May 27
2021
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
42,955
+8.03%
|
-
|